Myeloma Genomics and Microenvironment and immune profiling
Category: Myeloma Genomics and Microenvironment and immune profiling
Clinical Impact of Cytogenetic Abnormalities and Detection Discordance between Conventional Karyotyping and FISH in Multiple Myeloma
Ji Hyun Lee, MD, PhD
Professor
Dong-A University College of Medicine
The median age was 66 years, and the median follow-up duration was 24.7 months. Cytogenetic abnormalities were identified in 82.6% of patients. Anemia was significantly more common in the abnormal karyotype group (P=0.01). Among clinical variables, only age >65 years was significantly associated with inferior OS (P=0.02). The most common abnormalities were del(13q) (17.9%), dup(1q21) (13.8%), hyperdiploidy (11.9%), and t(11;14) (9.2%). Among these, del(13q) (P=0.03), hypodiploidy (P=0.008), and dup(1q21) (P=0.01) were significantly associated with worse OS. Notably, 33.7% of cases showed discordant results between CCA and FISH. In particular, patients with dup(1q21) detected by CCA had significantly poorer survival outcomes (P=0.002).
Conclusions: This study confirms that specific cytogenetic abnormalities, especially del(13q), hypodiploidy, and dup(1q21), are associated with inferior survival in MM. Moreover, discrepancies between CCA and FISH were common, and in the case of dup(1q21), detection by CCA provided more prognostic relevance. These findings highlight the complementary roles of both cytogenetic techniques and suggest the need for integrated interpretation in MM prognostication.